Pibrentasvir (ABT-530) is a novel and pan-genotypic hepatitis C virus (HCV) NS5A inhibitor with EC50 ranging from 1.4 pM to 5.0 pM against HCV replicons containing NS5A from genotypes 1 to 6.
Molecular Weight:
1113.18
Purity:
>99.0%
CAS Number:
[1353900-92-1]
Formula:
C57H65F5N10O8
Target:
HCV Protease
* VAT and and shipping costs not included. Errors and price changes excepted